SPONSOR
Peking University First Hospital
Total Trials
8
Recruiting
8
Phases
Phase 4, Phase 1, Phase 2, Phase 3
Conditions studied: Cerebellar AtrophyEtiologyPhysiopathologyParturientsAccidental Puncture of Dura During AnaesthesiaEpidural FillingHydroxyethyl StarchPost-dural Puncture HeadacheProstate CancerCommunity-based Screening
Peking University First Hospital is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Cerebellar Atrophy, Etiology, Physiopathology, Parturients.
The trial portfolio spans Phase 4, Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Peking University First Hospital
How many clinical trials has Peking University First Hospital sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Peking University First Hospital, of which 8 are actively recruiting participants. These trials cover conditions including Cerebellar Atrophy, Etiology, Physiopathology. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Peking University First Hospital research focus on?
Peking University First Hospital clinical trials span Cerebellar Atrophy, Etiology, Physiopathology, Parturients, Accidental Puncture of Dura During Anaesthesia, and additional conditions. The research pipeline includes Phase 4, Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Peking University First Hospital clinical trial?
To participate in a Peking University First Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Peking University First Hospital trials with current recruitment status updated daily.
Clinical Trials by Peking University First Hospital
NCT07166432
Recruiting
Development, Application, and Mechanistic Investigation of a Novel Minimally-Invasive Bidirectional Epidural Cerebellar Stimulation Technique for Cerebellar Cognitive Affective Syndrome
Cerebellar Atrophy
NCT07914790
Recruiting
Epidural Hydroxyethyl Starch for Post-Dural Puncture Headache in Parturients
Parturients
NCT07319923
Recruiting
Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing
Prostate Cancer
NCT06399185 Phase 4
Recruiting
Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort
Urinary Catheter
NCT07693036 Phase 1, Phase 2
Recruiting
hUC-MSC-Exosomes for T2DM - Safety & Efficacy
Type 2 Diabetes Mellitus (T2DM)
NCT06842264
Recruiting
The Development and Validation of MRI-AI-based Predictive Models for csPCa
Prostate Cancer
NCT07498907 Phase 3
Recruiting
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
NCT07605156
Recruiting
Diagnostic Value of 68Ga-Pentixafor PET/CT in Adrenal Tumors With Aldosterone and Cortisol Cosecretion
Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology